Reyom Pharmaceuticals Private Limited
About Reyom Pharmaceuticals Private Limited
Data last updated:
Reyom Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 07 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC333547.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Fruti Kumari and Rajeev Ranjan.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at A – 13 3rd Floor Ganesh Nagar Pandav Nagar, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.98 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹208 (net margin -0.1%) and EBITDA of ₹1,546 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years.
Company details
Contact details
Reyom Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 13 3rd Floor Ganesh Nagar Pandav Nagar, New Delhi, Delhi, India – 110092
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Reyom Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reyom Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Reyom Pharmaceuticals Private Limited, buy the company report.
Financials of Reyom Pharmaceuticals Private Limited
FY 2023 filings availableReyom Pharmaceuticals Private Limited reported revenue of ₹1.98 Lakh (up 1% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over three years, including 1% growth in the latest year. EBITDA fell 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,546 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹208 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reyom Pharmaceuticals Private Limited, buy the company report.
Board of directors of Reyom Pharmaceuticals Private Limited
Reyom Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Fruti Kumari | Director | 07 May 2018 | 8 Years 5 Months | Current |
| Rajeev Ranjan | Director | 07 May 2018 | 8 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Reyom Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reyom Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Reyom Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Reyom Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Fruti Kumari was appointed as Director on 07 May 2018.
Frequently asked questions
Reyom Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 07 May 2018 (8+ years old) and is registered under CIN U74999DL2018PTC333547.
Reyom Pharmaceuticals has 2 current directors:
- Fruti Kumari - Director
- Rajeev Ranjan - Director
The latest financial statements of Reyom Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Reyom Pharmaceuticals is U74999DL2018PTC333547. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reyom Pharmaceuticals was incorporated on 07 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Fruti Kumari was appointed as Director on 07 May 2018. Rajeev Ranjan was appointed as Director on 07 May 2018.
The registered office of Reyom Pharmaceuticals is at A – 13 3rd Floor Ganesh Nagar Pandav Nagar, New Delhi, Delhi, India – 110092.
Reyom Pharmaceuticals operates in the business services industry, in the other services segment.
Reyom Pharmaceuticals can be reached at its registered office: A – 13 3rd Floor Ganesh Nagar Pandav Nagar, New Delhi, Delhi, India – 110092.
Reyom Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
